P44
Hepatitis D remains overrepresented and undertreated in prison populations: data from Catalonia, Spain
A. Marco, A. Palom, I. Abdo, A. Rando-Segura, L. Calatayud, G. Fernández-Rivas, A. Sellés, S. Mormeneo , D. Pérez del Campo, E. del Corral, ED. Gil-Tubella, M. Buti
P47
High prevalence of HDV and HBV detected amongst household contacts of HDV positive individuals in rural Sindh
A. Ali, H. Ahmed, SM. Channa, C. Strobel, M. Rodgers, S. Gawel, F. Averhoff, G. Cloherty, E. Khan, N. Ghanchi, SS. Hamid
P49
Global burden and geographic concentration of hepatitis delta virus infection across 195 countries in 2020: A modeling study
M. Papatheodorid, J. Paik, K. AlNaamani, G. Papatheodoridis, M. Buti, A. Paik, T. Kushner, C. Villela-Nogueira, S. Gidaagaya, B. Munkhbat, M. Yu, J. Ong, Y. Eguchi, M. El-Kassas, P. Lampertico, Y. Yilmaz, C. Spearman, Z. Younossi
P50
Clinical phenotype of hepatitis D according to HIV serostatus: results from the nationwide DDR Spain cohort
A. Alberola, A. de Salazar, A. Fuentes, R. Carracedo, M. Illescas-López, L. Pérez-Rodríguez, A. Vázquez-Blanquiño, M. Cabezas Fernández, C. Freyre, B. Becerril, I. Viciana, I. López-Rodríguez, N. Montiel Quezel-Guerraz, S. Bernal, J. Borrego, E. Ramírez A
P51
Where should we look for hepatitis D? Community versus hospital-based screening in Romanian migrants in Catalonia, Spain.
A. Palom, J. Gómez i Prat, T. Rafi, S. Malik, L. Buldum, I. Abdó, A. Marco, P. Huelin, C. Aracil Blanch, C. Lopez, T. Balari, J. Castellote, R. Maria Morillas, M. Buti
P52
National registry of patients with hepatitis D: real-world clinical practice data in Spain
A. Pocurull, A. Palom, Á. Giráldez, JC Ruiz Cobo, M. Casado, S. Lorente, J. García-Samaniego, M. Molina, R. González Monasterio, I. Fernández, C. Delgado, J. Cabezas, MJ. Devesa, JM. Rosales, N. García Gimeno, M. García-Retortillo, MD. Antón Conejero, R.
P53
Epidemiology and clinical characteristics of hepatitis delta virus infection in Belgium: Final results of a nationwide double HDV reflex testing study
M. Coessens, F. Lemaitre, I. Roukaerts, J. Wawrzyniak, M. Steverlynck, M. Van Esbroeck, BJ. Visser, M. Reda, M. De Vos, M. Reynders, H. Orlent, H. Van-poucke, C. De Vloo, M. De Spiegeleer, J. Van Acker, L. Coremans, T. Banica, E. Padalko, X. Verhelst, H.
P54
Seroprevalence and viral biomarker characterization of hepatitis D infection in treatment naive-infected blood donors with hepatitis B in Cameroon
R. Kamga Wouambo, N. Ashukem Taku, N. S. Ateba, M. Pfefferkorn, S. Nkongolo, GE. Gnouamozi, M. Matz-Soja, S. Urban, T. Berg, F. van Bömmel, F. Ngo Nsack
P55
Reflex testing reveals a significant HDV burden across Europe and increases HDV diagnosis at an early stage
I. Grossi, R. Salpini, C. Tramontozzi, I. Alexiev, L. Baiocchi, L. Banica, T. Banica, J. Begovac, B. Benkoova, A. Bertoli, S. Bopegamage, C. Caudai, S. D’anna, T. Demir, C. Devaux, A. Di Lorenzo, G. Fernández-Rivas, K. Gazdikova, A. M. Geretti, E. Golkoch
P57
Hepatitis delta screening and treatment cascade among people with HIV and chronic hepatitis B in Milan
T. Clemente, A.R. Raccagni, R. Lolatto, H. Hasson, E. Messina, M. Ripa, V. Spagnuolo, A. Danise, M. Guffanti, P. Cinque, D. Canetti, S. Nozza, A. Castagna
